Hypoxic radioresistance: can ROS be the key to overcome it?

H Wang, H Jiang, M Van De Gucht, M De Ridder - Cancers, 2019 - mdpi.com
Radiotherapy is a mainstay treatment for many types of cancer and kills cancer cells via
generation of reactive oxygen species (ROS). Incorporating radiation with pharmacological …

The role of thioredoxin system in cancer: strategy for cancer therapy

JJ Jia, WS Geng, ZQ Wang, L Chen… - Cancer chemotherapy and …, 2019 - Springer
Purpose Cancer, a major public health problem, exhibits significant redox alteration.
Thioredoxin (Trx) system, including Trx and Trx reductase (TrxR), as well as Trx-interacting …

Molecular pathways associated with oxidative stress and their potential applications in radiotherapy

R Liu, Y Bian, L Liu, L Liu, X Liu… - … Journal of Molecular …, 2022 - spandidos-publications.com
Radiotherapy is an essential and effective treatment modality for cancer. Excessive levels of
reactive oxygen species (ROS) induced by ionizing radiation disrupt the redox homeostasis …

Auranofin and cold atmospheric plasma synergize to trigger distinct cell death mechanisms and immunogenic responses in glioblastoma

J Van Loenhout, L Freire Boullosa, D Quatannens… - Cells, 2021 - mdpi.com
Targeting the redox balance of malignant cells via the delivery of high oxidative stress
unlocks a potential therapeutic strategy against glioblastoma (GBM). We investigated a …

Hypoxic tumor microenvironment: Implications for cancer therapy

S Roy, S Kumaravel, A Sharma… - Experimental …, 2020 - journals.sagepub.com
Hypoxia or low oxygen concentration in tumor microenvironment has widespread effects
ranging from altered angiogenesis and lymphangiogenesis, tumor metabolism, growth, and …

[HTML][HTML] Auranofin: Past to Present, and repurposing

M Yamashita - International Immunopharmacology, 2021 - Elsevier
Auranofin (AF), a gold compound, has been used to treat rheumatoid arthritis (RA) for more
than 40 years; however, its mechanism of action remains unknown. We revealed that AF …

Significance of the mitochondrial thioredoxin reductase in cancer cells: An update on role, targets and inhibitors

V Scalcon, A Bindoli, MP Rigobello - Free Radical Biology and Medicine, 2018 - Elsevier
Abstract Thioredoxin reductase 2 (TrxR2) is a key component of the mitochondrial
thioredoxin system able to transfer electrons to peroxiredoxin 3 (Prx3) in a reaction mediated …

Oxidative stress-inducing anticancer therapies: taking a closer look at their immunomodulating effects

J Van Loenhout, M Peeters, A Bogaerts, E Smits… - Antioxidants, 2020 - mdpi.com
Cancer cells are characterized by higher levels of reactive oxygen species (ROS) compared
to normal cells as a result of an imbalance between oxidants and antioxidants. However …

Multifunctional AuI‐based AIEgens: Manipulating Molecular Structures and Boosting Specific Cancer Cell Imaging and Theranostics

J Zhang, H Zou, J Lei, B He, X He… - Angewandte Chemie …, 2020 - Wiley Online Library
Gold (I) N‐heterocyclic carbene (AuI‐NHC) complexes have emerged as potential
anticancer agents owing to their high cytotoxicity and stability. Integration of their above …

Auranofin/vitamin C: a novel drug combination targeting triple-negative breast cancer

E Hatem, S Azzi, N El Banna, T He… - JNCI: Journal of the …, 2019 - academic.oup.com
Background Cancer cells from different origins exhibit various basal redox statuses and thus
respond differently to intrinsic or extrinsic oxidative stress. These intricate characteristics …